TPO and autoimmune thrombocytopenic purpura: This could be due to different observation subjects: this study observed the differences in miRNAs between ITP patients and normal healthy controls, while Dr. Lamya Garabet's team observed the differences in miRNAs in ITP patients before and after TPO-RA treatment.